10 documents found, page 1 of 1

Sort by Issue Date

Epidemiological, behavioural and molecular profile of individuals newly diagnos...

da Veiga Leal, Silvânia; de Pina Araújo, Isabel Inês; Pimentel, Victor; Parreira, Ricardo; Gonçalves, Paloma; Pingarilho, Marta; Taveira, Nuno

Introduction: The diagnosis of HIV with Transmitted Drug Resistance Mutations (TDR) limits therapeutic options and consequently complicates the management of HIV-1 cases. Objective: The aim of this study was to describe the molecular epidemiological profile and TDR in individuals newly diagnosed with HIV-1 from 2018 to 2020. Materials and methods: The HIV-1 pol gene was amplified and sequenced using the Sanger ...


Perfil epidemiológico, comportamental e molecular de indivíduos recém-diagnosti...

Leal, Silvânia da Veiga; Araújo, Isabel Inês de Pina; Pimentel, Victor; Parreira, Ricardo; Gonçalves, Paloma; Pingarilho, Marta; Taveira, Nuno

Introdução: O diagnóstico de VIH com Mutações de Resistência Transmitida (TDR) limita a opção terapêuticas e consequentemente dificulta a gestão de casos VIH-1. Objetivo: Este artigo tem como objetivo descrever o perfil epidemiológico molecular e de TDR em indivíduos com diagnóstico recente de VIH-1, no período de 2018 a 2020. Materiais e métodos: O gene pol VIH-1 foi amplificado e sequenciado pelo método Sange...


HIV-1 antiretroviral drug resistance in Mozambique : a systematic review and me...

Gonçalves, Paloma; Mascarenhas, Paulo; Marcelino, Rute; Mabunda, Nédio; Kroidl, Arne; Buck, W. Chris; Jani, Ilesh; Palladino, Claudia; Taveira, Nuno

This systematic review assessed the prevalence of transmitted and acquired HIV drug resistance (HIVDR) and the associated risk factors in Mozambique. A search of the PubMed, Cochrane, B-On, and Scopus databases up to December 2023 was conducted and included 11 studies with 1118 HIV-1 pol sequences. Drug resistance mutations (DRMs) to NNRTIs were found in 13% of the drug-naive individuals and 31% of those on ART...


Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isola...

Martin, Francisco; Marcelino, José Maria; Palladino, Claudia; Bártolo, Inês; Tracana, Susana; Moranguinho, Inês; Gonçalves, Paloma; Mateus, Rita

A minority of HIV-1-infected patients produce broadly neutralizing antibodies (bNAbs). Identification of viral and host correlates of bNAb production may help develop vaccines. We aimed to characterize the neutralizing response and viral and host-associated factors in Angola, which has one of the oldest, most dynamic, and most diverse HIV-1 epidemics in the world. Three hundred twenty-two HIV-1- infected adults...


Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isola...

Martin, Francisco; Marcelino, José Maria; Palladino, Claudia; Bártolo, Inês; Tracana, Susana; Moranguinho, Inês; Gonçalves, Paloma; Mateus, Rita

A minority of HIV-1-infected patients produce broadly neutralizing antibodies (bNAbs). Identification of viral and host correlates of bNAb production may help develop vaccines. We aimed to characterize the neutralizing response and viral and host-associated factors in Angola, which has one of the oldest, most dynamic, and most diverse HIV-1 epidemics in the world. Three hundred twenty-two HIV-1-infected adults ...


High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lact...

Bártolo, Inês; Moura, Ines; Gonçalves, Paloma; Diniz, Ana Rita; Borrego, Pedro; Martin, Francisco; Figueiredo, Inês; Gomes, Perpétua

Integrase inhibitors (INIs) are an important class of drugs for treating HIV-2 infection,given the limited number of drugs active against this virus. While the clinical efficacy of raltegravirand dolutegravir is well established, the clinical efficacy of bictegravir for treating HIV-2 infected patients has not been determined. Little information is available regarding the activity of bictegravir against HIV-2 i...


Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isola...

Martin, Francisco; Marcelino, José Maria; Palladino, Claudia; Bártolo, Inês; Tracana, Susana; Moranguinho, Inês; Gonçalves, Paloma; Mateus, Rita

A minority of HIV-1-infected patients produce broadly neutralizing antibodies (bNAbs). Identification of viral and host correlates of bNAb production may help develop vaccines. We aimed to characterize the neutralizing response and viral and host-associated factors in Angola, which has one of the oldest, most dynamic, and most diverse HIV-1 epidemics in the world. Three hundred twenty-two HIV-1-infected adults ...


High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-ß-Lact...

Bártolo, Inês; Moranguinho, Inês; Gonçalves, Paloma; Ana Rita Diniz; Borrego, Pedro; Martin, Francisco; Figueiredo, Inês; Gomes, Perpetua

Integrase inhibitors (INIs) are an important class of drugs for treating HIV-2 infection, given the limited number of drugs active against this virus. While the clinical efficacy of raltegravir and dolutegravir is well established, the clinical efficacy of bictegravir for treating HIV-2 infected patients has not been determined. Little information is available regarding the activity of bictegravir against HIV-2...


High instantaneous inhibitory potential of Bictegravir and the new Spiro-β-Lact...

Bártolo, Inês; Moranguinho, Inês; Gonçalves, Paloma; Diniz, Ana Rita; Borrego, Pedro; Martin, Francisco; Figueiredo, Inês; Gomes, Perpétua

Integrase inhibitors (INIs) are an important class of drugs for treating HIV-2 infection, given the limited number of drugs active against this virus. While the clinical efficacy of raltegravir and dolutegravir is well established, the clinical efficacy of bictegravir for treating HIV-2 infected patients has not been determined. Little information is available regarding the activity of bictegravir against HIV-2...


Long-term and low-level envelope C2V3 stimulation by highly diverse virus isola...

Martin, Francisco; Marcelino, José Maria; Palladino, Claudia; Bártolo, Inês; Tracana, Susana; Moranguinho, Inês; Gonçalves, Paloma; Mateus, Rita

A minority of HIV-1-infected patients produce broadly neutralizing antibodies (bNAbs). Identification of viral and host correlates of bNAb production may help develop vaccines. We aimed to characterize the neutralizing response and viral and host-associated factors in Angola, which has one of the oldest, most dynamic, and most diverse HIV-1 epidemics in the world. Three hundred twenty-two HIV-1-infected adults ...


10 Results

Queried text

Refine Results

Author





















Date



Document Type



Funding



Access rights


Resource




Subject